| Effect | None |
| Trial Design | Double blind |
| Trial Length | 1-6 months |
| Number of Subjects | 46 |
| Sex | Both Genders |
| Age Range | 45-64, 65+ |
| Body Types | Overweight |
Supplementation of EPA (720mg) and DHA (280mg), but not DHA in isolation (720mg), was able to decrease NK cell activity independent of NK cell content to about 20% (8 weeks) and 48% (12 weeks).
No treatment influence lipid peroxidation (TBARS)
